Pre-Health Discussion Forum:Patents & Pills, Prices & Profits
Discussion Questions: 1. Should the US introduce some form of price regulation for medicines? If so, how? 2. Intellectual property protections - mainly in the form of patents - are supposed to create incentives for innovation - including drug development. How well do you think this is working? Are there any possible alternatives to the current model? Readings: a. Scannell J. Four Reasons Drugs Are Expensive, Of Which Two Are False. Forbes.com October 13, 2015. https://www.forbes.com/sites/matthewherper/2015/10/13/four-reasons-drugs-are-expensive-of-which-two-are-false/#767128974c3b b. Light D, Lexchin J. Foreign free riders and the high price of US medicines BMJ 2005:331:958-60. http://www.bmj.com/content/331/7522/958.full.pdf c. Schrag D. The Price Tag on Progress — Chemotherapy for Colorectal Cancer. N Engl J Med 2004;351(4):317-319. http://www.nejm.org/doi/pdf/10.1056/NEJMp048143 d. Lakdawalla DN,Goldman DP,Michaud PC, Sood N. US Pharmaceutical Policy In A Global Marketplace. Health Affairs 2009;28(1):w138- w150. http://content.healthaffairs.org/content/28/1/w138.long
Categories |
|
---|---|
When |
Oct 20, 2017 from 01:30 pm to 03:30 pm |
Hosting organization | Pre-Health Advising Office |
Speaker | Various Speakers |
Speaker Information | Various Speakers |
Where | Hunter 710 |
Add event to calendar |
vCal iCal |
Click here to RSVP